Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,736 | 137 | 718 | N/A | N/A |
| Marketable Securities | 2,250 | N/A | N/A | N/A | N/A |
| Receivables | 165 | 16 | 14 | N/A | N/A |
| Other current assets | 6,000 | 0 | 0 | 0 | 0 |
| TOTAL | $32,151 | $153 | $732 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 774 | 13 | 30 | N/A | N/A |
| TOTAL | $774 | $13 | $30 | $N/A | $N/A |
| Total Assets | $32,925 | $166 | $762 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 20 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,118 | 1,689 | 493 | 0 | 0 |
| TOTAL | $1,118 | $1,689 | $513 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 400 | 428 | 2,228 | 0 | 0 |
| TOTAL | $400 | $428 | $2,228 | $N/A | $N/A |
| Total Liabilities | $1,518 | $2,117 | $2,741 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 32 | 10 | 7 | N/A | N/A |
| Retained earnings | -36,745 | -27,642 | -10,157 | N/A | N/A |
| Other shareholders' equity | 4 | 0 | 3,724 | 0 | 0 |
| TOTAL | $31,407 | $-1,951 | $-1,979 | $N/A | $N/A |
| Total Liabilities And Equity | $32,925 | $166 | $762 | $0 | $0 |